Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,333 across all filing types
Latest filing 2026-06-08 Regulatory Filings
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer - Attachment: Release.pdf
Regulatory Filings Classification · 75% confidence The document is a corporate press release announcing a research collaboration between Photocure and Artera on AI-powered bladder cancer diagnostics. It does not contain financial statements, management changes, earnings data, or any regulatory form certification. It is not a report itself nor an announcement of a report being published. It does not fit any specific category such as earnings release, M&A, dividend, or capital update. Therefore, it falls into the fallback category “Regulatory Filings” (RNS) for miscellaneous corporate announcements.
2026-06-08 English
Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer
Regulatory Filings Classification · 15% confidence The document is a corporate press release announcing a research collaboration between Photocure and Artera on AI-based diagnostics for bladder cancer. It does not present financial results, management changes, regulatory filings like a 10-K or 8-K, proxy materials, or other specialized filings. It is a general business update/fallback announcement and therefore falls under the Regulatory Filings (RNS) category.
2026-06-08 English
Photocure ASA - Notice of the Annual General Meeting 26 June 2026 - Attachment: 20260604_PHO_Proposed_resolutions_AGM_2026_norsk.pdf
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a set of proposed resolutions, agenda items, and supporting information for the upcoming ordinary general meeting of Photocure ASA (26 June 2026). It is provided to shareholders so they can review and vote on matters such as approval of annual accounts, board and auditor remuneration, election of directors, and share-issuance/repurchase authorizations. This matches the definition of a Proxy Solicitation & Information Statement (materials sent to shareholders to inform and request votes ahead of a meeting), rather than an actual annual report, earnings release, or voting-results announcement.
2026-06-05 Norwegian Bokmål
Photocure ASA - Notice of the Annual General Meeting 26 June 2026 - Attachment: English_Photocure_ASA_AGM_notice_2026.pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is the official notice convening the Annual General Meeting, including agenda items, proxy and voting instructions, and materials sent to shareholders to request their votes. This aligns with the definition of Proxy Solicitation & Information Statement (PSI) rather than a post‐meeting report or simple report announcement.
2026-06-05 English
Photocure ASA - Notice of the Annual General Meeting 26 June 2026 - Attachment: 20260605_PHO_Nomination_Commitee_valgkomiteen_AGM_2026.pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a report and recommendation from the company’s Nomination Committee submitted ahead of the Annual General Meeting, detailing proposed board and committee compositions, remuneration and voting items. It is part of the proxy materials that inform shareholders and solicit their votes at the AGM, rather than the AGM minutes or the final vote results. Therefore it should be classified as Proxy Solicitation & Information Statement.
2026-06-05 English
Photocure ASA - Notice of the Annual General Meeting 26 June 2026 - Attachment: Norsk_Photocure_ASA_AGM_notice_2026.pdf
Proxy Solicitation & Information Statement Classification · 92% confidence The document is the official ‘innkalling’ (notice and agenda) for Photocure ASA’s ordinary general shareholders’ meeting, sent to shareholders with proposals and proxy/voting instructions. It is not the meeting minutes, results, or a financial report, but rather proxy solicitation and information materials provided prior to the AGM. Therefore, it fits the Proxy Solicitation & Information Statement category.
2026-06-05 Norwegian Bokmål

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.